Patent · US Active

Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions

US8110177B2 · kind B2 · utility

65Cited by
127References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2010
Grant dateFeb 7, 2012
Priority date
Expiry dateApr 27, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory, halitosis, tinnitus, sugar craving, autism, attention deficit/hyperactivity disorder, drug sensitivity, an autoimmune disease, and Crohn's disease. Also disclosed are a method of screening for the abnormally likely presence of SIBO in a human subject and a method of detecting SIBO in a human subject. A method of determining the relative severity of SIBO or a SIBO-caused condition in a human subject, in whom small intestinal bacterial overgrowth (SIBO) has been detected, is also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.